Lonza Group AG (LON:0QNO)
559.61
+6.89 (1.25%)
Jan 22, 2026, 5:08 PM GMT
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of 36.71 billion as of January 22, 2026. Its market cap has increased by 7.50% in one year.
Market Cap
36.71B
Enterprise Value
40.24B
Revenue
6.51B
Ranking
n/a
PE Ratio
54.57
Stock Price
559.61
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 2.30B to 36.71B, an increase of 1,493.49%. That is a compound annual growth rate of 11.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 36.71B | 3.54% |
| Dec 30, 2025 | 35.46B | 4.00% |
| Dec 30, 2024 | 34.10B | 39.19% |
| Dec 29, 2023 | 24.50B | -18.81% |
| Dec 30, 2022 | 30.17B | -34.20% |
| Dec 30, 2021 | 45.85B | 30.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.86B |
| GSK plc | 71.72B |
| Haleon | 33.60B |
| Smith & Nephew | 10.34B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.37B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.87B |